pharmaceuticals

IPO

Selecta Biosciences Files for IPO

Selecta Biosciences has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were listed in the filing, but the offering ...
Read Full Story »
Pfizer

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Needless to say, the health care sector, especially pharmaceuticals and biotech, have taken a rhetorical beating from politicians looking to force the blame for high drug prices on some of the ...
Read Full Story »
Female patient on gurney

5 Major Clinical Trial Results Coming Up

Pharmaceutical and biotech companies generally must endure the lengthy process that is getting their drug candidates to market through clinical trials. There is a fair amount to a great amount ...
Read Full Story »
white pills

Short Sellers Take Mixed Stance on Major Pharma

The short interest data have been released for the May 13 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
automatic inspection machine

PDL’s Next Acquisition Target Focus Is on Hypertension

PDL BioPharma Inc. (NASDAQ: PDLI) has now shown where its next revenue stream will be coming from. The company announced on Tuesday that it has committed to an equity investment ...
Read Full Story »
IPO

Selecta Biosciences Files for IPO: Targeting Gout

Selecta Biosciences has filed its paperwork with the Securities and Exchange Commission to conduct an initial public offering (IPO) ahead. The company applied to list its common stock on The ...
Read Full Story »
graph

8 Stocks on the Move After ASCO Cancer Abstracts

The American Society of Clinical Oncology (ASCO) is in the process of setting up for its annual meeting in Chicago. In this meeting, companies and cancer drug developers will share ...
Read Full Story »
white pills

Could This Be the Turning Point for Tonix Pharma?

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) watched its shares take a handy jump early on Thursday, following positive results from its mid-stage post-traumatic stress disorder (PTSD) study. The company announced top-line ...
Read Full Story »
IPO

Reata Pharma Fills in the Blanks for Its IPO

Reata Pharmaceuticals registered an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, but ...
Read Full Story »
surgery

Did Valeant Pharmaceuticals Capitulate Its Pricing?

Valeant Pharmaceuticals International Inc. (NYSE: VRX) has been at the heart of controversy for quite a while now, at a royal expense to its shareholders. The stock is currently valued ...
Read Full Story »
Pfizer

Pfizer Pays $5.2 Billion for Anacor

Pfizer Inc. (NYSE: PFE) announced Monday that it has reached a definitive agreement to acquire Anacor Pharmaceuticals Inc. (NASDAQ: ANAC) for $99.25 a share in cash. Net of Anacor's cash ...
Read Full Story »
IPO

Oncobiologics IPO Collapses 20%

The Oncobiologics Inc. (NASDAQ: ONSIU) initial public offering suffered a devastating first day. Shares ended down 20% to $4.80. The equity being offered was not via traditional common shares: Oncobiologics, Inc. ...
Read Full Story »
100 dollar bills

Parnell Pharma Gears Up for Secondary Offering

Parnell Pharmaceuticals Holdings Ltd. (NASDAQ: PARN) saw its shares drop by over 10% early Thursday following the pricing of its secondary offering. The company announced the pricing of its offering ...
Read Full Story »
child with cancer

ASCO Could Make or Break These 7 Cancer Drug Trials

It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. ...
Read Full Story »
white pills

Major Pharma Short Interest Continues to Recede

The short interest data have been released for the April 29 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »